Product Headline

Using patented SAMiRNA technology, this formula targets the root cause of androgenic alopecia at the hair follicle. Androgenic alopecia occurs in scalp areas with raised androgen levels. This hormone binds to androgen receptors, thus triggering hair loss. To counteract this phenomenon, Bioneer Corp.’s formula targets androgen receptors. The product, delivered via a syringe-like applicator and applied once every two weeks, penetrates the hair follicle via the pores in the scalp. There, the CosmeRNA68 ingredient acts to down-regulate the over-stimulated androgen receptor, thus reducing hair loss. This action sidesteps the hormonal side effects that traditional anti-hair loss treatments that block DHT can induce, such as loss of libido and changes in mood. A clinical study in Europe by Dermatest demonstrated that the CosmeRNA Anti-Hair Loss Tonic improved androgenic alopecia after applying 1ml every two weeks for six months.

Product description

Introducing CosmeRNA, a groundbreaking solution revolutionizing hair care. Harnessing the power of advanced RNA technology, CosmeRNA offers a unique Anti-Hair Loss formula for fuller, healthier hair for everyone suffering from Androgenic Alopecia. Androgenic Alopecia manifests in specific scalp areas where androgen levels rise, binding to androgen receptors, subsequently triggering hair loss. Integrated with SAMiRNA™ technology, CosmeRNA precisely targets the Androgen Receptor, effectively addressing Androgenic Alopecia with safety and convenience. As the first RNA-based hair care innovation, CosmeRNA is introduced and recommended as an emerging Anti-hair loss solution by trusted experts, endorsed and beloved by users worldwide.

Claims & Benefits

The solid science-based cosmeceutical utilizes siRNA with a published clinical study. The clinical results revealed a 90% response rate and a 7.5 increase in hair counts per square centimeter. Enhanced user convenience is another key competency, as it only requires topical applications every two weeks, thanks to the intrinsic long-acting efficacy of siRNA to address hair loss at the genetic level. CosmeRNA's siRNA technology offers targeted care for the root cause protein of Androgenic Alopecia without affecting hormones, making it a superior solution for individuals with this condition.

Technical details

This product contains over 30% of CosmeRNA68, the first anti-hair loss RNA ingredient that addresses Androgenic alopecia at the molecular level. CosmeRNA68 integrates patented SAMiRNA (Self-Assembled-Micelle inhibitory RNA), an innovative siRNA platform technology for topical delivery. The INCI name represents the specific molecular composition of CosmeRNA68. This formulation ensures stability at temperatures exceeding 50 ℃ and facilitates penetration into the hair follicle through the pores. Additionally, Panthenol promotes skin regeneration, creating a healthier scalp environment, while Biotin nourishes hair strands for improved hair health, and menthol stimulates blood circulation. Ethanol serves as an effective preservative substitute, offering cooling and cleansing effects on the scalp.

Launch date

05/10/2023

Price List, Target Consumer & Market Segments

In the hair loss market, diverse care options are available, including medical devices and localized therapies like minoxidil. It is crucial to carefully select a care option based on various factors, including gender, age, and the type of hair loss. Androgenic Alopecia is the most common type of hair loss, affecting 80% of men and 50% of women in Europe. However, current treatment options for Androgenic Alopecia can have serious side effects like erectile dysfunction and are not recommended for women. CosmeRNA is an excellent option for individuals experiencing Androgenic Alopecia, priced at approximately 100 euros per month.

What sets your product apart and why is it innovative?

CosmeRNA stands out as a groundbreaking innovation in the market for androgenetic alopecia, addressing critical unmet customer needs and overcoming challenges that have long hindered effective treatment options. Unlike conventional treatments plagued by side effects, limited availability across genders, discomfort, and inconsistency in use, CosmeRNA offers a revolutionary solution. Leveraging cutting-edge molecular science based on Nobel prize awarded technologies including si-RNA since 1992, CosmeRNA introduces an innovative cosmeceutical approach. At its core lies patented SAMiRNA technology, enabling targeted delivery of RNA molecules to address the root cause of hair loss. This breakthrough not only resolves existing issues but also enhances accessibility for customers, offering a safer, more effective, and convenient option for androgenetic alopecia.

How do you promote your product on multiple channels?

After successfully meeting legal compliance in the EU and UK through CPNP and SCPN notification systems, CosmeRNA is now easily accessible to customers through Amazon Europe and our official online mall. Through strategic efforts such as engaging in diverse activities on our SNS channels and showcasing at academies or congresses, CosmeRNA has gained global recognition as a groundbreaking solution for androgenic alopecia by professionals worldwide. In our commitment to bolster product credibility, we are actively forging partnerships for clinical evaluation with dermatologists and experts, participating in a range of events including Aesthetic Medicine Academies, congresses, and cosmetic exhibitions.

Website and Social Channel/s

The visual and communication aspects of CosmeRNA can be accessed through our website and two primary social media channels.
Website: www.cosmerna.com 
Instagram: https://www.instagram.com/cosmerna_official?igsh=ZWlhZmEyOXpqMXpj 
Facebook: https://www.facebook.com/cosmerna 
Youtube: https://www.youtube.com/@cosmerna_official

Patents

The siRNA technology for hair loss care has been applied and granted under the title of "Double-stranded oligonucleotide targeting DKK1, oligonucleotide structure comprising the same, and composition comprising the same for preventing hair loss and promoting hair growth."

How does your product meet the evaluation criteria of its category?

The market for androgenetic alopecia faces unmet customer needs related to safety, limited availability for all genders, discomfort, and challenges maintaining consistency of use, while encountering obstacles in developing solutions involving siRNA. CosmeRNA was developed as a cosmetic to address these issues and enhance accessibility. The novel and innovative anti-hair loss ingredient, cosmerna68 provides a groundbreaking solution for androgenic alopecia by overcoming challenges in developing siRNA as a cosmetic. It utilizes a patented delivery system to target and inhibit the expression of androgen receptor mRNA in hair follicles. Due to its size of approximately 80nm, it can penetrate the hair follicles through the pores in affected areas with the assistance of massage techniques. Specifically, a specially designed silicone-tip integrated package will facilitate and enhance this massage technique, making it easier and more effective. CosmeRNA stands out for its safety by acting topically instead of traditional systematic action. Moreover, using once every 2 weeks on desired area is sufficient to experience its effects, thanks to the intrinsic long-acting efficacy of siRNA. Therefore, we are submitting this product in the hair product category of the Cosmoprof award due to its innovative approach to the hair care market, integrating new siRNA technology to usher in the true RNA cosmetic era.

What is your brand commitment to sustainability, ethical practices, and social responsibility? Please describe.

Bioneer, operating in South Korea and the US, has built an in-house system spanning Research and Development (R&D) to the production of DNA/RNA raw materials. Standing as the first Korean biotech company that commercialized DNA/RNA synthesis and molecular diagnosis, this is achieved by leveraging the world's premier production facilities and drawing upon a rich 30-year history in the biotech field. CosmeRNA68, our in-house produced synthetic ingredient, reflects our commitment to sustainability We do not conduct tests on animals. In our commitment to providing effective, safe, and the finest value-priced hair care products for the global hair loss market, we will continue our research and development efforts tirelessly.

Certifications

From the clinical study in Europe by Dermatest, CosmeRNA Anti-Hair loss tonic has shown a clear result of ameliorating Androgenic Alopeicia, by applying 1ml every 2 weeks for 6 months, Additionally, no claims for any adverse effects has been reported among the 120 subjects; proudly accompanied by Dermatest’s 5-star certification for the skin reliance. Additionally, CosmeRNA has met the legal compliance in the EU and the UK through CPNP and SCPN notification system.